Prognostic and Diagnostic Value of Ambulatory Blood Pressure Monitoring

Hypertension

Volumn , Issue , 2005, Pages 305-317

  Parati, Gianfranco ^a,b   Bilo, Grzegorz ^a,b   Mancia, Giuseppe ^a,c,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d Centro Fisiologia Clinica e Ipertensione   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884202878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50117-4     Document Type: Chapter

References (74)

1. Riva-Rocci S Un nuovo sfigmomanometro. Gazzetta Medica di Torino 1896, 50:981-996.
2. O'Brien E Replacing the mercury sphygmomanometer. BMJ 2000, 320:815-816.
3. O'Brien E Will mercury manometers soon be obsolete?. J Hum Hypertens 1995, 9:933-934.
4. Mancia G, Parati G, Di Rienzo M, et al. Blood pressure variability. Pathophysiology of Hypertension. [Vol. 17 of Handbook of Hypertension] 1997, 117-169. Elsevier Science BV, Amsterdam. A. Zanchetti, G. Mancia (Eds.).
5. Bevan AT, Honour AJ, Stott FH Direct arterial pressure recording in unrestricted man. Clin Sci 1969, 36:329-344.
6. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variability in normotensive and hypertensive human beings. Circ Res 1983, 53:96-104.
7. Mancia G, Bertineri G, Grassi G, et al. Effects of blood pressure measured by the doctor on patient's blood pressure and heart rate. Lancet 1983, 2:695-698.
8. Mancia G, Parati G, Pomidossi G, et al. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987, 9:209-215.
9. Penaz J. Photoelectric measurement of blood pressure, volume, and flow in the finger. Digest 10th Int Conf Med Biol Eng Dresden 104 (abstract), 1973.
10. Parati G, Casadei R, Groppelli A, et al. Comparison of finger and intraarterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989, 13:647-655.
11. Imholz BPM, Langewouters GJ, van Montfrans GA, et al. Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension 1993, 21:65-73.
12. Bos WJW, van Goudever J, van Montfrans GA, et al. Reconstruction of brachial artery pressure from non-invasive finger pressure measurements. Circulation 1996, 94:1870-1875.
13. Parati G, Ongaro G, Bilo G, et al. Non-invasive beat-to-beat blood pressure monitoring: New developments. Blood Press Monit 2003, 8:31-36.
14. Mancia G, Parati G, Castiglioni P, et al. Daily life blood pressure changes are steeper in hypertensive than in normotensive subjects. Hypertension 2003, 42:277-282.
15. Parati G, Mancia G Ambulatory blood pressure monitoring. Manual of Hypertension 2002, 153-171. Churchill Livingstone, London. G. Mancia, J. Chalmers, S. Julius (Eds.).
16. Hinman AT, Engel BT, Bickford AF Portable blood pressure recorder-Accuracy and preliminary use in evaluating intradaily variations in pressure. Am Heart J 1962, 63:663.
17. Sokolow M, Werdegar D, Kain HK, et al. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966, 34:279-298.
18. Perloff D, Sokolow M, Cowan R The prognostic value of ambulatory blood pressures. JAMA 1983, 249(20):2792-2798.
19. American National Standard Electronic or automated sphygmomanometers. ANSI/AAMI SP 10-1992 1993, 40. Association for the Advancement of Medical Instrumentation, Arlington, VA.
20. O'Brien E, Petrie J, Littler WA, et al. The British Hypertension Society Protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993, 11(suppl 2):S43-S63.
21. O'Brien E, Pickering T, Asmar R, et al. [with the statistical assistance of Atkins N, Gerin W]; Working Group on Blood Pressure Monitoring of the European Society of Hypertension. International protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002, 7:3-17.
22. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003, 21:821-848.
23. O'Brien E, Waeber B, Parati G, et al. Blood pressure measuring devices: Recommendations of the European Society of Hypertension. BMJ 2001, 322:531-536.
24. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003, 21:1011-1053.
25. Mancia G, Parati G Ambulatory blood pressure monitoring and organ damage. Hypertension 2000, 36:894-900.
26. Devereux RB, Pickering TG Relationship between variability of ambulatory blood pressure and target hypertension. J Hypertens 1991, 8:S34-S38.
27. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage. J Hypertens 1987, 5:93-98.
28. Liu JE, Roman Mj, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999, 131:564-572.
29. Pessina AC, Palatini P, Sperti G, et al. Evaluation of hypertension and related target organ damage by average day-time blood pressure. Clin Exp Hypertens [A] 1985, 7:267-278.
30. Rowlands DB, Ireland MA, Glover DR, et al. The relationship between ambulatory blood pressure and echocardiographically assessed left ventricular hypertrophy. Clin Sci (Lond) 1981, 61(Suppl 7):101S-103S.
31. Zanchetti A, Bomd MG, Hennig M, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998, 16:949-961.
32. Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993, 11:1133-1137.
33. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997, 95:1464-1470.
34. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994, 24:793-801.
35. Redon J, Campos C, Narciso ML, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study. Hypertension 1998, 31:712-718.
36. Imai Y, Ohkubo T, Sakuma M, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: A prospective observation in a cohort from Ohasama, Northern Japan. Blood Press Monit 1996, 1:251-254.
37. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999, 282:539-546.
38. Clement DL, De Buyzere ML, De Bacquer DA Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003, 348:2407-2415.
39. Palatini P, Mormino P, Santonastaso M, et al. Ambulatory blood pressure predicts end-organ damage only in subjects with reproducible recordings. HARVEST Study Investigators. Hypertension and Ambulatory Recording Venetia Study. J Hypertens 1999, 17:465-473.
40. Fagard RH, Staessen JA, Thijs L Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997, 29:22-29.
41. Fagard RH, Staessen JA, Thijs L Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997, 15:1493-1502.
42. Parati G, Mutti E, Ravogli A, et al. Advantages and disadvantages of non-invasive ambulatory blood pressure monitoring. J Hypertension 1990, 8(Suppl 6):S33-S38.
43. Mancia G, Di Rienzo M, Parati G Ambulatory blood pressure monitoring: Use in hypertension research and clinical practice. Hypertension 1993, 21:500-524.
44. Parati G, de Leeuw P, Illyes M, et al. Blood pressure measurement in research. Blood Press Monit 2002, 7:83-87.
45. Parati G, Pomidossi G, Casadei V, et al. Lack of alerting reactions and pressor responses to intermittent cuff inflations during non-invasive blood pressure monitoring. Hypertension 1985, 7:597-601.
46. Mancia G, Omboni S, Parati G, et al. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995, 8:311-315.
47. Parati G, Bilo G, Vettorello M, et al. Assessment of overall blood pressure variability and its different components. Blood Press Monit 2003, 8:155-159.
48. Sander D, Kukla C, Klingelhofer J, et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000, 102:1536-1541.
49. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: The Ohasama Study. Hypertension 2000, 38:23-29.
50. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992, 10:875-878.
51. Pringle E, Phillips C, Thijs L, et al. on behalf of the Syst-Eur Investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003, 21:2251-2257.
52. Liu JG, Xu LP, Chu ZX, et al. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 2003, 21:1961-1967.
53. Verdecchia P Prognostic value of ambulatory blood pressure: Current evidence and clinical implications. Hypertension 2000, 35:844-885.
54. Kario K, Matsuo T, Kobayashi H, et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996, 27:130-135.
55. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: Prospective evidence from the SAMPLE study. J Hypertens 1998, 16:733-738.
56. Rocco MB, Barry J, Campbell S, et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987, 75:395-400.
57. White W Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit 2001, 6:63-72.
58. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003, 107:1401-1406.
59. Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: Results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002, 39:710-714.
60. Verdecchia P, Borgioni C, Ciucci A, et al. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit 1996, 1:3-11.
61. Di Rienzo M, Grassi G, Pedotti A, et al. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 1983, 5:264-269.
62. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension?. JAMA 1988, 259:255-258.
63. Parati G, Bilo G, Mancia G White coat effect and white coat hypertension: What do they mean?. Cardiovasc Rev Rep 2003, 24:477-484.
64. CMS Centers for Medicare & Medicaid Services. Medicare Coverage Policy. Decisions: ABPM monitoring (#CAG-00067N) http://www.hcfa.gov/coverage/8b3-ff.htm?
65. Verdecchia P, O'Brien E, Pickering T, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. Statement from the working group on blood pressure monitoring of the European Society of Hypertension. Am J Hypertens 2003, 16:87-91.
66. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560-2572.
67. O'Brien E Ambulatory blood pressure measurement is indispensable to good clinical practice. J Hypertens Suppl 2003, 21(Suppl 2):S11-S18.
68. Mancia G, Omboni S, Ravogli A, et al. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: Additional information from a large data base. Blood Press 1995, 4:148-156.
69. Mancia G Clinical benefits of consistent reduction in the daily blood pressure of hypertensive patients. J Clin Hypertens (Greenwich) 2002, 4(Suppl 1):9-14.
70. Parati G, Omboni S, Rizzoni D, et al. The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998, 16:1685-1691.
71. Rizzoni D, Muiesan ML, Salvetti M, et al. The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens 2001, 19:703-711.
72. Stergiou GS, Efstathiou SP, Skeva II, et al. Comparison of the smoothness index, the trough: Peak ratio and the morning: evening ratio in assessing the features of the antihypertensive drug effect. J Hypertens 2003, 21:913-920.
73. Hond ED, Celis H, Fagard R, et al. Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens 2003, 21:717-722.
74. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157:2413-2446.